...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma.
【24h】

Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma.

机译:三维保形放射治疗局部复发性鼻咽癌的剂量学和临床结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To assess the dosimetric and clinical results of three-dimensional conformal radiotherapy (3D CRT) for locally recurrent nasopharyngeal carcinoma (NPC). METHODS: A total of 86 patients with locally recurrent NPC were retreated with 3D CRT. The median prescribed dose was 68 Gy with 2 Gy per fractionation. Dosimetric quality was evaluated with dose distribution in planning target volume (PTV) and specified organs at risk (OAR), dose conformity index (CI) and dose homogeneity index (HI). The actuarial rate of local failure-free (LFF), overall survival (OS) and major late toxicities (MLT) were estimated with Kaplan-Meier method. Multivariate analysis for prognosis was performed using the Cox regression proportional hazards model. RESULTS: The mean dose to PTV averaged 66.8 Gy, and the dose to specified OAR was acceptable. The average value of CI and HI was 0.59 and 9.1%. The 5-year actuarial rate of LFF and OS was 71 and 40%, respectively. The 5-year actuarial incidence of MLT>or=Grade 3 and >or=Grade 4 were 100 and 49%, respectively. The major prognostic factors were T stage and the size of gross tumor volume (GTV). Advanced T stage and large GTV volume were associated with poor LFF and OS and high risk of MLT. CONCLUSION: The dosimetric quality of 3D CRT for locally recurrent NPC is generally excellent. A relatively high local control was achieved with this technique. However, the incidence of late toxicities were not found to decrease as originally expected. Early diagnosis of the recurrence and reasonable definition of the target volume are crucial to achieve a better outcome.
机译:目的:评估三维适形放疗(3D CRT)治疗局部复发性鼻咽癌(NPC)的剂量学和临床结果。方法:总共86例局部复发的鼻咽癌患者接受了3D CRT治疗。中位处方剂量为68 Gy,每次分次为2 Gy。剂量学质量通过计划目标体积中的剂量分布(PTV)和特定风险器官(OAR),剂量一致性指数(CI)和剂量均一性指数(HI)进行评估。用Kaplan-Meier方法估算局部无故障(LFF),总体生存率(OS)和主要后期毒性(MLT)的精算率。使用Cox回归比例风险模型进行多因素预后分析。结果:PTV的平均剂量为66.8 Gy,指定的OAR剂量是可以接受的。 CI和HI的平均值为0.59和9.1%。 LFF和OS的5年精算率分别为71%和40%。 MLT≥3级和≥4级的5年精算发生率分别为100%和49%。主要的预后因素是T期和总肿瘤体积(GTV)大小。晚期T期和大量GTV与LFF和OS差以及MLT高风险有关。结论:局部复发性鼻咽癌的3D CRT的剂量学质量通常是优良的。用这种技术实现了相对较高的局部控制。但是,未发现后期毒性的发生率与最初预期的一样降低。复发的早期诊断和目标体积的合理定义对于取得更好的结果至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号